Solid Tumor Profile Plus™
Use
Solid Tumor Profile Plus™ is tailored for a wide array of solid tumors, integrating DNA and RNA sequencing methods for comprehensive analysis. The profile covers mutations, amplifications, and significant fusions like ALK, ROS1, and NTRK1/2/3. It highlights key expressions such as PD-L1 and BRAF, aiding significantly in prognosis and therapeutic matching in diverse cancer types, including CUP.
Special Instructions
Not provided.
Limitations
Performance limitations exist regarding the quality of the FFPE samples, which affect the efficiency of mutation detection and amplification assessment. Variability in fixation quality impacts RNA quality and thus fusion detection.
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
7-10 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
1 H&E slide and 6-8 unstained slides
Collection Instructions
Fixed with 10% NBF